1568 / 1726
17
Take home messages
Elective lymph node target: 45-50Gy EBRT
Perspective of reducing morbidity with 45Gy
Pathological lymph nodes: 55-60Gy EBRT
Balance between tumour control and morbidity
Primary tumour (CTV
HR
):
>85-90Gy EBRT+BT
Balance between EBRT and BT
With more IC/IS BT it is possible to reduce EBRT dose to
45Gy
Overall treatment time:
<50 days